Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRT-NPC: Optimization of Cervical Nodal Clinical Tumor Volume for Early and Medium Stage Nasopharyngeal Carcinoma
NCT05145660Phase 3Active, not recruiting
- Start
- Sep 2022
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nasopharyngeal carcinoma (NPC) (2 arms). Primary endpoint: Regional-recurrence-free survival at 3 years. Started Sep 2022; status: active, not recruiting.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05145660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05145660.